Navigation Links
ev3 Inc. to Present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference
Date:5/27/2008

PLYMOUTH, Minn., May 27 /PRNewswire/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Robert Palmisano, president and chief executive officer, is scheduled to present at the Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference on Tuesday, June 10, 2008 at 11:00 a.m. PT (2:00 p.m. ET and 1:00 p.m. CT). The Goldman Sachs Twenty-Ninth Annual Global Healthcare Conference will be held at the Ritz-Carlton Laguna Niguel in Dana Point, California.

To access the webcast, go to the investors' section of the ev3 Web site at http://www.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to improving the lives of patients with vascular disease through the development of innovative endovascular therapies. ev3's products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.


'/>"/>
SOURCE ev3 Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Pharsight Invited to Present on Modeling and Simulation at ARCS Australia Scientific Congress
2. Watson to Present at the UBS Global Specialty and Generic Pharmaceuticals Conference
3. Bioniche Presents Pre-Clinical Research at Two International Conferences
4. VNUS Medical Technologies to Present at FBR Capital Markets 12th Annual Spring Investor Conference
5. Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference
6. Aflac Incorporated to Present at the Sanford C. Bernstein & Co., LLC Twenty-Fourth Annual Strategic Decisions Conference 2008
7. DURECT Corporation Presenting at the 2008 UBS Global Generic and Specialty Pharmaceuticals Conference
8. Study presented at DDW 2008 Confirms that New Device Significantly Improves Detection of Polyps in the Colon
9. Hologic to Present at NASDAQs 21st Investor Program in London
10. CryoCath Presents at Prestigious Heart Rhythm Society Meeting
11. Mercury Computer Systems to Present at the Cowen and Company 20/20 Technology-Media-Telecom Conference on May 29, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2014)... In a world enveloped in technological ... lessened, and due to the intrusion of cell ... has eroded. According to Web MD, one in ... http://www.webmd.com/sleep-disorders/features/sleep-deprivation-workplace ). This remarkably high number lowers ... amount, leading not only to dissatisfied employers, but ...
(Date:11/27/2014)... HealthDay Reporter , WEDNESDAY, Nov. ... to acquire a second language, new research suggests. But anyone ... gain a brain boost, the small study finds. ... study co-author Ping Li, co-director of the Center for Brain, ... more interesting, Li said, that "the brain networks of the ...
(Date:11/27/2014)... The founders of VIM & VIGR, a company ... compression socks, are proud to announce the debut of their ... Pressure (TM) knitting technology that is designed to increase the ... to adding flair and style to a product that has ... eye of a writer at The New York Times ...
(Date:11/27/2014)... (PRWEB) November 27, 2014 VogueQueen.com is ... items for ladies across the world. As the premier ... accessories, VogueQueen.com is proud to release a huge selection ... high quality outfits, it is also providing many beautiful ... VogueQueen prom gowns at discounted prices. , “VogueQueen.com ...
(Date:11/27/2014)... Texas (PRWEB) November 27, 2014 ... report on Global Insulin industry. For an overview ... definition, classification, application, industry chain structure, industry overview, ... on global Insulin industry covers information on ... process, product cost structure and much more. ...
Breaking Medicine News(10 mins):Health News:Research Shows Surprising Number of US Workers Affected by Lack of Sleep 2Health News:Some People May Be Pre-Wired to Be Bilingual 2Health News:Some People May Be Pre-Wired to Be Bilingual 3Health News:VIM & VIGR Announces Launch of Men’s Line of Compression Socks 2Health News:A New Collection of Sexy Prom Dresses Has Been Released by the Reliable Online Supplier VogueQueen.com 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 2Health News:Insulin Industry Analysis (Supply, Consumption) for China, America, Korea, France & Japan Research Now at ReportsnReports 3
... Feb. 3 Noticing a few extra hairs in your,comb ... conceal areas of,thinning hair rather than a fashion choice? Are ... growth? If you answered,yes to any of these questions, you ... of hair loss. But to whom should you turn for ...
... importance of physical activities to improve balance , , SUNDAY, Feb. ... one in three seniors over age 65, and almost one ... this year -- in some cases, leading to serious disability ... their balance and reduce their risk of falls are expected ...
... patient safety enhancements to dramatically reduce errors and improve ... obstetrical care. , Edmund F. Funai, M.D., associate ... Sciences at Yale, will present preliminary results from this ... Meeting on February 2 in Dallas, Texas. , An ...
... February is American Heart Month, a,time when experts say ... to,reduce risk for heart disease. Here,s more on how ... but just eat the right kind for good heart ... Association of Margarine,Manufacturers at: http://media.medialink.com/WebNR.aspx?story=34443 , Registered ...
... potential for patients with specific gene mutations, researchers find ... sorafenib shows promise in the treatment of people with ... U.S. researchers. , Previous research has shown that sorafenib ... -- is effective against acute myeloid leukemia cells that ...
... LOUISVILLE, Ky., Feb. 1 Ventas, Inc. ... it has completed the,sale of 4,485,000 shares of ... registration statement. The amount includes 585,000 shares,of common ... of the,underwriter,s overallotment option. The Company received net ...
Cached Medicine News:Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 2Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 3Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 4Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 5Health News:Don't Let Hair Loss Tangle You Up: Dermatologists Can Identify Common Hair Disorders and Offer Solutions 6Health News:Toll-Free Hotline to Help Seniors Avoid Falls 2Health News:New strategy helps reduce errors in obstetrical care 2Health News:Sorafenib Slows Growth of Some Leukemias 2Health News:Ventas Completes Previously Announced Sale of Common Stock 2Health News:Ventas Completes Previously Announced Sale of Common Stock 3Health News:Ventas Completes Previously Announced Sale of Common Stock 4
(Date:11/26/2014)... , Nov. 26, 2014  Cohen, Placitella & ... of investors who purchased Nymox Pharmaceutical Corporation ("Nymox" ... the period from January 31, 2011 through November ... Nymox and certain of its officers and directors ... violation of Sections 10(b) and 20(a) of the ...
(Date:11/26/2014)... 2014   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... CEO of Regulus, will present a company overview at ... at the New York Palace Hotel on Wednesday, December ... be webcast at the time of the presentation and ...
(Date:11/26/2014)... , November 26, 2014 Investor-Edge ... VVUS ), Horizon Pharma PLC (NASDAQ: ... and Johnson (NYSE: JNJ ), and Theravance Inc. ... companies can be accessed at: http://investor-edge.com/register . ... 4,758.25, up 0.07%, the Dow Jones Industrial Average edged 0.02% ...
Breaking Medicine Technology:Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 2Cohen, Placitella & Roth, PC Investigating Nymox Pharmaceutical Corporation for Failing to Disclose Material Information 3Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 2Regulus to Present at the 26th Annual Piper Jaffray Healthcare Conference and Genetic Rx Conference 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 2Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 3Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 4Pharma Stocks Highlight - VIVUS, Horizon Pharma, Endocyte, Johnson and Johnson, and Theravance 5
... Calif., May 9, 2011 Alexza Pharmaceuticals, Inc. (Nasdaq: ... the fiscal quarter ended March 31, 2011, and provided ... ended March 31, 2011 and 2010, as reported in ... States, was $8.4 million and $13.4 million, respectively.  At ...
... Inc. (OTC: LPTN), the category leader in bioactive-lipid-targeted therapeutics, ... available for on-demand viewing. LINK: www.retailinvestorconferences.com ... button. Lpath, Inc.,s presentation will be available ... from the "virtual trade booth" for the next three ...
Cached Medicine Technology:Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 2Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 3Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 4Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 5Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 6Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 7Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 8Alexza Reports 2011 First Quarter Financial Results and Provides Business Update 9Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 2Lpath, Inc. CEO Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: